Xonacef XP 500mg/250mg Injection
Marketer
Positive Medicare Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Xonacef XP 500mg/250mg Injection
Cefixime and Sulbactam injection (Xonacef XP 500mg/250mg) combats various bacterial infections by inhibiting microbial growth and spread. This dual-action medication requires administration by a healthcare professional; strict adherence to the prescribed dosage and schedule is crucial for effective treatment. Premature cessation may compromise its efficacy. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Severe or persistent reactions necessitate immediate medical attention. Allergic responses (rash, itching, swelling, respiratory distress) demand immediate medical help. Inform your physician about all current medications, and pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration support recovery. Your doctor may order tests to monitor treatment effectiveness.
Uses of Xonacef XP 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Xonacef XP 500mg/250mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Xonacef XP 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xonacef XP 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Xonacef XP 500mg/250mg Injection works:
Xonacef XP Injection, containing 500mg Ceftriaxone and 250mg Sulbactam, utilizes a dual-drug approach to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby maximizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xonacef XP 500mg/250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xonacef XP (500mg/250mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Xonacef XP 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Xonacef XP 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Xonacef XP 500mg/250mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Xonacef XP 500mg/250mg Injection requires careful consideration in individuals with significant hepatic impairment. Dosage modification of Xonacef XP 500mg/250mg Injection may be necessary. Physician consultation is advised. Altering the dosage of Xonacef XP 500mg/250mg Injection is not suggested for patients experiencing mild to moderate liver dysfunction.
What if you forget to take Xonacef XP 500mg/250mg Injection :
Should you inadvertently omit a dose of Xonacef XP 500mg/250mg Injection, seek medical advice.
Facts to Know About Xonacef XP 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently